Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06143852 · ClinicalTrials.gov registry record · NA

Change in Social Media Use and Well-being Among College Students Receiving a One-week Exercise or Mindfulness Intervention

A NA study of Depression, Anxiety and Well-Being, Psychological, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT06143852: Completed NA study of Depression, Anxiety and Well-Being, Psychological, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT06143852 is a NA study of Depression, Anxiety and Well-Being, Psychological that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 140 participants, below the 421-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06143852, a NA study of Depression, Anxiety and Well-Being, Psychological, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The investigators will be randomizing 150 college student participants with high levels of social media use into either a 1) control condition (no intervention), a 2) mindfulness meditation cognitive intervention, or 3) a social media reduction + exercise replacement intervention. Participants complete intervention activities daily for one week. The investigators will collect self-report and behavioral measures of social media use and related psychological constructs at three time points: baseline, immediately after the intervention period, and one-week after the intervention period.

Primary Outcome

Score range = 0-63, higher score = worse outcome

Interventions

  • BEHAVIORAL Mindfulness
  • BEHAVIORAL Social Media Reduction + Exercise

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2024-02-07
Est. Completion 2024-12-11
Phase NA

What the finished NCT06143852 record still lists

NCT06143852 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 421-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (67% lower).

The record links to 3 conditions, with Depression, Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness is the first listed.

NCT06143852 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06143852 about?

NCT06143852 is a clinical study titled "Change in Social Media Use and Well-being Among College Students Receiving a One-week Exercise or Mindfulness Intervention". The investigators will be randomizing 150 college student participants with high levels of social media use into either a 1) control condition (no intervention), a 2) mindfulness meditation cognitive intervention, or 3) a social media reduction + exercise replacement intervention. Participants compl...

What is the current status of trial NCT06143852?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2024-02-07. Estimated completion is 2024-12-11.

What conditions does trial NCT06143852 study?

This clinical trial studies the following conditions: Depression, Anxiety, Well-Being, Psychological, Social Media Addiction.

What interventions are being tested in trial NCT06143852?

The interventions under investigation include: Mindfulness (BEHAVIORAL), Social Media Reduction + Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT06143852?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06143852 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression, Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06143852's enrollment target sits among peer trials

140 21st of 40 higher than 19 of 40 other Depression, Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06143852, the US trial registry maintained by the National Library of Medicine. NCT06143852 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.